Creatine Monohydrate for Strength & Performance — Performance & Recovery
The most extensively studied and evidence-backed sports supplement, with strong evidence for strength, power output, and lean mass gains across all populations.
Overview
Creatine monohydrate is the most extensively studied ergogenic supplement in sports nutrition history, with over 1,000 peer-reviewed publications supporting its efficacy and safety. Creatine is a naturally occurring guanidino compound synthesized endogenously from arginine, glycine, and methionine primarily in the liver and kidneys (~1 g/day), with additional intake from meat and fish (~1-2 g/day in omnivores). Approximately 95% of the body's creatine (120-140 g in a 70 kg individual) is stored in skeletal muscle, predominantly as phosphocreatine (PCr). The phosphocreatine energy system is the first-line energy buffer during high-intensity, short-duration exercise — creatine kinase rapidly transfers the phosphate group from PCr to ADP, regenerating ATP faster than any other metabolic pathway. Supplementation with creatine monohydrate (typically 3-5 g/day after optional loading phase) increases intramuscular creatine and PCr stores by 20-40%, significantly improving performance in repeated high-intensity efforts, maximal strength, power output, and total training volume. A meta-analysis of 22 studies found creatine increased maximal strength by an average of 8% and repetitions to failure by 14% compared to placebo. Beyond performance, emerging evidence supports cognitive benefits (particularly under sleep deprivation or hypoxia), neuroprotection, improved bone mineral density in postmenopausal women, and potential benefits in depression. The International Society of Sports Nutrition position stand (2017) states that creatine monohydrate is the most effective nutritional supplement available for increasing high-intensity exercise capacity and lean body mass.
Indications
- Strong evidence: Increased maximal strength and power output
- Strong evidence: Enhanced high-intensity exercise performance and training volume
- Strong evidence: Increased lean body mass / muscle mass
- Moderate evidence: Cognitive function under stress, sleep deprivation, and hypoxia
- Moderate evidence: Post-exercise recovery (reduced muscle damage markers)
- Emerging evidence: Neuroprotection, bone health (postmenopausal), depression adjunct
Mechanism of Action
Oral creatine monohydrate is absorbed and transported to skeletal muscle via creatine transporter (SLC6A8), increasing intramuscular creatine and phosphocreatine stores by 20-40%
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Creatine monohydrate | 5 g | Four times daily for 5-7 days | Loading phase (optional); saturates stores in ~1 week |
| Creatine monohydrate | 3-5 g | Once daily | Maintenance dose; saturates stores in ~3-4 weeks without loading |
| Creatine monohydrate | 0.1 g/kg/day | Once daily | Weight-based dosing alternative; ~7 g for 70 kg individual |
Evidence Grade
GRADE A
Safety & Contraindications
- Extensively studied safety profile — no evidence of renal, hepatic, or cardiac harm in healthy individuals
- Initial water retention (1-2 kg) due to osmotic effect of intracellular creatine accumulation — not fat gain
- GI discomfort (bloating, cramping) possible during loading phase — mitigated by splitting doses
- Does NOT cause dehydration, muscle cramps, or rhabdomyolysis — these myths are debunked
- Safe for long-term use — studies up to 5 years show no adverse effects
- Creatine monohydrate is the only form with sufficient evidence — other forms (HCl, ethyl ester, etc.) are not superior